Clinical Trials Directory

Trials / Completed

CompletedNCT02313090

Study of Welltang- a Cell Phone-based Diabetes Management Application's Effect on Blood Glucose Control

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim was to assess the impact of a cell phone-based diabetes management application (Welltang) on HbA1c, blood glucose, lipids, physical activity, weight, and blood pressure during 3 months. And hypoglycemic events, the satisfaction of the patients with Boyibang, their diabetes knowledge and self-care behaviors were also evaluated.

Detailed description

At baseline, all patients completed the Diabetes Self- Care Behavior Questionnaire and a Diabetes Knowledge Survey. Health, medical and demographic history, height and weight, waist and hip circumferences, and blood pressure were recorded. HbA1c and low-density lipoprotein cholesterol (LDL-C) level were tested. All of these data were measured 3 months later at the conclusion of the study intervention.

Conditions

Interventions

TypeNameDescription
OTHERWelltangThe intervention group installed Welltang (downloaded from www.welltang.com for free) designed by Shanghai Geping Information and Technique Company Ltd (Shanghai, China) on their cell phones. Welltang is a cell phone- based diabetes management application that consists of three main parts: knowledge, self-management, communication between patients and clinicians

Timeline

Start date
2014-01-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2014-12-09
Last updated
2014-12-09

Source: ClinicalTrials.gov record NCT02313090. Inclusion in this directory is not an endorsement.